Unacceptable Principal Diagnosis Codes
ICD-10-CM codes identified as unacceptable when used as principal diagnosis by MCE edit logic.
- T45.96XSBillable
Underdosing of unspecified primarily systemic and hematological agent, sequela
- T46.0X5ABillable
Adverse effect of cardiac-stimulant glycosides and drugs of similar action, initial encounter
- T46.0X5DBillable
Adverse effect of cardiac-stimulant glycosides and drugs of similar action, subsequent encounter
- T46.0X5SBillable
Adverse effect of cardiac-stimulant glycosides and drugs of similar action, sequela
- T46.0X6ABillable
Underdosing of cardiac-stimulant glycosides and drugs of similar action, initial encounter
- T46.0X6DBillable
Underdosing of cardiac-stimulant glycosides and drugs of similar action, subsequent encounter
- T46.0X6SBillable
Underdosing of cardiac-stimulant glycosides and drugs of similar action, sequela
- T46.1X5ABillable
Adverse effect of calcium-channel blockers, initial encounter
- T46.1X5DBillable
Adverse effect of calcium-channel blockers, subsequent encounter
- T46.1X5SBillable
Adverse effect of calcium-channel blockers, sequela
- T46.1X6ABillable
Underdosing of calcium-channel blockers, initial encounter
- T46.1X6DBillable
Underdosing of calcium-channel blockers, subsequent encounter
- T46.1X6SBillable
Underdosing of calcium-channel blockers, sequela
- T46.2X5ABillable
Adverse effect of other antidysrhythmic drugs, initial encounter
- T46.2X5DBillable
Adverse effect of other antidysrhythmic drugs, subsequent encounter
- T46.2X5SBillable
Adverse effect of other antidysrhythmic drugs, sequela
- T46.2X6ABillable
Underdosing of other antidysrhythmic drugs, initial encounter
- T46.2X6DBillable
Underdosing of other antidysrhythmic drugs, subsequent encounter
- T46.2X6SBillable
Underdosing of other antidysrhythmic drugs, sequela
- T46.3X5ABillable
Adverse effect of coronary vasodilators, initial encounter
- T46.3X5DBillable
Adverse effect of coronary vasodilators, subsequent encounter
- T46.3X5SBillable
Adverse effect of coronary vasodilators, sequela
- T46.3X6ABillable
Underdosing of coronary vasodilators, initial encounter
- T46.3X6DBillable
Underdosing of coronary vasodilators, subsequent encounter
- T46.3X6SBillable
Underdosing of coronary vasodilators, sequela
- T46.4X5ABillable
Adverse effect of angiotensin-converting-enzyme inhibitors, initial encounter
- T46.4X5DBillable
Adverse effect of angiotensin-converting-enzyme inhibitors, subsequent encounter
- T46.4X5SBillable
Adverse effect of angiotensin-converting-enzyme inhibitors, sequela
- T46.4X6ABillable
Underdosing of angiotensin-converting-enzyme inhibitors, initial encounter
- T46.4X6DBillable
Underdosing of angiotensin-converting-enzyme inhibitors, subsequent encounter
- T46.4X6SBillable
Underdosing of angiotensin-converting-enzyme inhibitors, sequela
- T46.5X5ABillable
Adverse effect of other antihypertensive drugs, initial encounter
- T46.5X5DBillable
Adverse effect of other antihypertensive drugs, subsequent encounter
- T46.5X5SBillable
Adverse effect of other antihypertensive drugs, sequela
- T46.5X6ABillable
Underdosing of other antihypertensive drugs, initial encounter
- T46.5X6DBillable
Underdosing of other antihypertensive drugs, subsequent encounter
- T46.5X6SBillable
Underdosing of other antihypertensive drugs, sequela
- T46.6X5ABillable
Adverse effect of antihyperlipidemic and antiarteriosclerotic drugs, initial encounter
- T46.6X5DBillable
Adverse effect of antihyperlipidemic and antiarteriosclerotic drugs, subsequent encounter
- T46.6X5SBillable
Adverse effect of antihyperlipidemic and antiarteriosclerotic drugs, sequela
- T46.6X6ABillable
Underdosing of antihyperlipidemic and antiarteriosclerotic drugs, initial encounter
- T46.6X6DBillable
Underdosing of antihyperlipidemic and antiarteriosclerotic drugs, subsequent encounter
- T46.6X6SBillable
Underdosing of antihyperlipidemic and antiarteriosclerotic drugs, sequela
- T46.7X5ABillable
Adverse effect of peripheral vasodilators, initial encounter
- T46.7X5DBillable
Adverse effect of peripheral vasodilators, subsequent encounter
- T46.7X5SBillable
Adverse effect of peripheral vasodilators, sequela
- T46.7X6ABillable
Underdosing of peripheral vasodilators, initial encounter
- T46.7X6DBillable
Underdosing of peripheral vasodilators, subsequent encounter
- T46.7X6SBillable
Underdosing of peripheral vasodilators, sequela
- T46.8X5ABillable
Adverse effect of antivaricose drugs, including sclerosing agents, initial encounter
- T46.8X5DBillable
Adverse effect of antivaricose drugs, including sclerosing agents, subsequent encounter
- T46.8X5SBillable
Adverse effect of antivaricose drugs, including sclerosing agents, sequela
- T46.8X6ABillable
Underdosing of antivaricose drugs, including sclerosing agents, initial encounter
- T46.8X6DBillable
Underdosing of antivaricose drugs, including sclerosing agents, subsequent encounter
- T46.8X6SBillable
Underdosing of antivaricose drugs, including sclerosing agents, sequela
- T46.905ABillable
Adverse effect of unspecified agents primarily affecting the cardiovascular system, initial encounter
- T46.905DBillable
Adverse effect of unspecified agents primarily affecting the cardiovascular system, subsequent encounter
- T46.905SBillable
Adverse effect of unspecified agents primarily affecting the cardiovascular system, sequela
- T46.906ABillable
Underdosing of unspecified agents primarily affecting the cardiovascular system, initial encounter
- T46.906DBillable
Underdosing of unspecified agents primarily affecting the cardiovascular system, subsequent encounter
- T46.906SBillable
Underdosing of unspecified agents primarily affecting the cardiovascular system, sequela
- T46.995ABillable
Adverse effect of other agents primarily affecting the cardiovascular system, initial encounter
- T46.995DBillable
Adverse effect of other agents primarily affecting the cardiovascular system, subsequent encounter
- T46.995SBillable
Adverse effect of other agents primarily affecting the cardiovascular system, sequela
- T46.996ABillable
Underdosing of other agents primarily affecting the cardiovascular system, initial encounter
- T46.996DBillable
Underdosing of other agents primarily affecting the cardiovascular system, subsequent encounter
- T46.996SBillable
Underdosing of other agents primarily affecting the cardiovascular system, sequela
- T47.0X5ABillable
Adverse effect of histamine H2-receptor blockers, initial encounter
- T47.0X5DBillable
Adverse effect of histamine H2-receptor blockers, subsequent encounter
- T47.0X5SBillable
Adverse effect of histamine H2-receptor blockers, sequela
- T47.0X6ABillable
Underdosing of histamine H2-receptor blockers, initial encounter
- T47.0X6DBillable
Underdosing of histamine H2-receptor blockers, subsequent encounter
- T47.0X6SBillable
Underdosing of histamine H2-receptor blockers, sequela
- T47.1X5ABillable
Adverse effect of other antacids and anti-gastric-secretion drugs, initial encounter
- T47.1X5DBillable
Adverse effect of other antacids and anti-gastric-secretion drugs, subsequent encounter
- T47.1X5SBillable
Adverse effect of other antacids and anti-gastric-secretion drugs, sequela
- T47.1X6ABillable
Underdosing of other antacids and anti-gastric-secretion drugs, initial encounter
- T47.1X6DBillable
Underdosing of other antacids and anti-gastric-secretion drugs, subsequent encounter
- T47.1X6SBillable
Underdosing of other antacids and anti-gastric-secretion drugs, sequela
- T47.2X5ABillable
Adverse effect of stimulant laxatives, initial encounter
- T47.2X5DBillable
Adverse effect of stimulant laxatives, subsequent encounter
- T47.2X5SBillable
Adverse effect of stimulant laxatives, sequela
- T47.2X6ABillable
Underdosing of stimulant laxatives, initial encounter
- T47.2X6DBillable
Underdosing of stimulant laxatives, subsequent encounter
- T47.2X6SBillable
Underdosing of stimulant laxatives, sequela
- T47.3X5ABillable
Adverse effect of saline and osmotic laxatives, initial encounter
- T47.3X5DBillable
Adverse effect of saline and osmotic laxatives, subsequent encounter
- T47.3X5SBillable
Adverse effect of saline and osmotic laxatives, sequela
- T47.3X6ABillable
Underdosing of saline and osmotic laxatives, initial encounter
- T47.3X6DBillable
Underdosing of saline and osmotic laxatives, subsequent encounter
- T47.3X6SBillable
Underdosing of saline and osmotic laxatives, sequela
- T47.4X5ABillable
Adverse effect of other laxatives, initial encounter
- T47.4X5DBillable
Adverse effect of other laxatives, subsequent encounter
- T47.4X5SBillable
Adverse effect of other laxatives, sequela
- T47.4X6ABillable
Underdosing of other laxatives, initial encounter
- T47.4X6DBillable
Underdosing of other laxatives, subsequent encounter
- T47.4X6SBillable
Underdosing of other laxatives, sequela
- T47.5X5ABillable
Adverse effect of digestants, initial encounter
- T47.5X5DBillable
Adverse effect of digestants, subsequent encounter
- T47.5X5SBillable
Adverse effect of digestants, sequela
